Clinical trial

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

NCT00851799

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Emtricitabine/tenofovir disoproxil fumarate Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ritonavir Normalized identity: ritonavirView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Atazanavir Normalized identity: atazanavirView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Raltegravir Normalized identity: raltegravirView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Darunavir Normalized identity: darunavirView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-06-01

PhaseN/A

Conditions

HIV Infectionverified · MONDO: HIV infectious disease

Interventions

Emtricitabine/tenofovir disoproxil fumarateDRUG

RitonavirDRUG · verified · RxNorm: ritonavir

AtazanavirDRUG · verified · RxNorm: atazanavir

RaltegravirDRUG · verified · RxNorm: raltegravir

DarunavirDRUG · verified · RxNorm: darunavir

Sponsors & collaborators

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infectionslead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Mapped research locations

BostonMassachusetts, United States2 ChicagoIllinois, United States2 Los AngelesCalifornia, United States2 ClevelandOhio, United States2 RochesterNew York, United States2 New YorkNew York, United States1 HoustonTexas, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1 AtlantaGeorgia, United States1 NashvilleTennessee, United States1 San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00851799 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.